Back to VIKING GLOBAL INVESTORS LP VIKING GLOBAL INVESTORS LP

AMLXAMLX
9 quarters

Position history for VIKING GLOBAL INVESTORS LPVIKING GLOBAL INVESTORS LP's holdings in AMYLYX PHARMACEUTICALS INC

VIKING GLOBAL INVESTORS LP previously held 0 shares of AMLX (AMYLYX PHARMACEUTICALS INC), worth $0 as of 2024-Q1.

Final Value

$0

Final Shares

0

Total Value Change

-$92.1M

Total Shares Change

-7.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q1
Latest
Exited
0
-100.0%
$00.0%$2.84
0
2023-Q4
Unchanged
3M
0.0%
$43.6M0.2%$14.72
0
2023-Q3
Unchanged
3M
0.0%
$54.2M0.2%$18.31
0
2023-Q2
Unchanged
3M
0.0%
$63.9M0.3%$20.98
0
2023-Q1
Decreased
3M
-36.1%
$86.9M0.4%$27.71
0
2022-Q4
Decreased
4.6M
-19.7%
$171.2M0.9%$36.95
0
2022-Q3
Decreased
5.8M
-19.5%
$162.4M0.8%$30.19
0
2022-Q2
Unchanged
7.2M
0.0%
$138.1M0.6%$18.18
0
2022-Q1
New
7.2M
-
$92.1M0.4%$14.93
49

Other major holders of AMLX: FMR LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used